Muvalaplin shows promise in lowering Lp(a) levels in clinical trial
A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein ...
Tag: Placebo
Weight loss drug semaglutide may offer relief for knee arthritis pain
New research highlights the potential for weight-loss medication to ease arthritis symptoms, offering hope for improved mobility and pain relief. ...
Diabetes drug semaglutide proves beneficial for patients with chronic kidney damage and obesity
The diabetes drug semaglutide, also known as Ozempic, has a positive effect for patients with chronic kidney damage and obesity. ...
Elderberry juice boosts fat burning and gut health in overweight adults
New research reveals that just one week of elderberry juice consumption significantly improves fat oxidation, glucose levels, and gut microbiota, ...
It's official! Men and women experience and manage pain differently
New study reveals that men rely on opioid-based systems to relieve pain while women may use unknown pathways, urging the ...
Semaglutide improves heart health and reduces weight in obese patients, but with side effects
Study shows that semaglutide not only aids in weight loss but also slashes heart failure risk by 76% in overweight ...
Combination treatment improves symptoms of agitated delirium in end-of-life cancer patients
Treatment with a combination of haloperidol and lorazepam reduced symptoms of agitated delirium, a common end-of-life condition for patients with ...
Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function
The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well ...
Thanks to Reddit, a new diagnosis is bubbling up across the nation
In a video posted to Reddit this summer, Lucie Rosenthal's face starts focused and uncertain, looking intently into the camera, ...
FINEARTS-HF trial shows finerenone benefits for heart failure with preserved ejection fraction
Finerenone reduced heart failure (HF) events and cardiovascular death in patients with HF and mildly reduced (HFmrEF) or preserved ejection ...
